Methodology for adaptation of the ASH Guidelines for Management of Venous Thromboembolism for the Latin American context
Por:
Neumann I., Izcovich A., Alexander K.E., Castano J., Plovnick R., Kunkle R., Zhang Y., Aguilar R., Basantes G.L., Casais P., Colorio C.C., Esposito M.C.G., Garcia Lazaro P.P., Pereira J., Meillon-Garcia L.A., Rezende S.M., Serrano J.C., Tejerina Valle M.L., Schunemann H.
Publicada:
1 ene 2021
Categoría:
Hematology
Resumen:
Background: From 2017 to 2020, the American Society of Hematology (ASH) collaborated with 12 hematology societies in Latin America to adapt the ASH guidelines on venous thromboembolism (VTE). Objective: To describe the methods used to adapt the ASH guidelines on venous thromboembolism. Methods: Each society nominated 1 individual to serve on the guideline panel. The work of the panel was facilitated by the 2 methodologists. The methods team selected 4 of the original VTE guidelines for a first round. To select the most relevant questions, a 2-step prioritization process was conducted through an on-line survey and then through in-person discussion. During an in-person meeting in Rio de Janeiro, Brazil, from 23 April through 26 April 2018, the panel developed recommendations using the ADOLOPMENT approach. Evidence about health effects from the original guidelines was reused, but important data about resource use, accessibility, feasibility, and impact in health equity were added. Results: In the guideline accompanying this paper, Latin American panelists selected 17 questions from an original pool of 49. Of the 17 questions addressed, substantial changes were introduced for 5 recommendations, and remarks were added or modified for 12 recommendations. Conclusions: By using the evidence from an international guideline, a significant amount of work and time were saved; by adding regional evidence, the final recommendations were tailored to the Latin American context. This experience offers an alternative to develop guidelines relevant to local contexts through a global collaboration. © 2021 by The American Society of Hematology
Filiaciones:
Neumann I.:
Department of Internal Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile
Pontificia Universidad Catolica de Chile, Avda. Libertador Bernardo O'Higgins 340, Santiago, 8331150, Chile
Izcovich A.:
Hospital Aleman, Buenos Aires, Argentina
Alexander K.E.:
American Society of Hematology, Washington, DC, United States
Castano J.:
American Society of Hematology, Washington, DC, United States
Plovnick R.:
American Society of Hematology, Washington, DC, United States
Kunkle R.:
American Society of Hematology, Washington, DC, United States
Zhang Y.:
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada
Aguilar R.:
Servicio de Hematologia, Complejo Hospitalario Dr. Arnulfo Arias Madrid, Panama City, Panama
Basantes G.L.:
Clinica Universitaria Colombia, Bogota, Colombia
Casais P.:
Epidemiologia Clinica y Evidencia, Instituto de Investigaciones en Salud Publica, Universidad de Buenos Aires, Buenos Aires, Argentina
Centro de Hematologia Pavlovsky, Buenos Aires, Argentina
Colorio C.C.:
Fundacion Favaloro, Buenos Aires, Argentina
Esposito M.C.G.:
Hospital de Clinicas Dr. Manuel Quintela, Montevideo, Uruguay
Garcia Lazaro P.P.:
Faculty of Medicine, Universidad Privada Antenor Orrego, Trujillo, Peru
Hospital Especializado Victor Lazarte Echegaray, Trujillo, Peru
Pereira J.:
Department of Hematology and Oncology, Pontificia Universidad Catolica de Chile, Santiago, Chile
Meillon-Garcia L.A.:
The ABC Medical Center, Mexico City, Mexico
Rezende S.M.:
Department of Internal Medicine, Faculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
Serrano J.C.:
Unidad Hematologica Especializada IPS, Cucuta, Colombia
Tejerina Valle M.L.:
Caja Petrolera de Salud, La Paz, Bolivia
Schunemann H.:
Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada
Bronze
|